O²-sulfo-D-glucose | 13077-93-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: O²-sulfo-D-glucose
• 英文别名: D-glucose 2-sulfate；glucose monosulfate；[(2R,3S,4R,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl] hydrogen sulfate
• CAS: 13077-93-5
• 化学式: C₆H₁₂O₉S
• 分子量: 260.222
• InChiKey: SZEJJURKOHIFBI-JGWLITMVSA-N

物化性质

• 密度：
  1.841±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -3.8
• 重原子数：
  16
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  170
• 氢给体数：
  5
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  O²-sulfo-D-glucose 在 盐酸 作用下， 以 水 为溶剂， 生成 葡萄糖
  参考文献：
  名称：

  On the desulphation of carbohydrate sulphates

  摘要：

  DOI：

  10.1016/0008-6215(83)88470-5

文献信息

• Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
  申请人：——

  公开号：US20010044144A1

  公开（公告）日：2001-11-22

  Compositions and methods are provided for producing adenine nucleotide translocator (ANT) polypeptides and fusion proteins, including the production and use of recombinant expression constructs having a regulated promoter. ANT ligands and compositions and methods for identifying ANT ligands, agents that bind ANT and agents that interact with ANT are also disclosed.

  本发明提供了用于制备腺嘌呤核苷酸转运蛋白（ANT）多肽和融合蛋白的组合物和方法，包括具有调节启动子的重组表达载体的制备和使用。本发明还公开了ANT配体和用于识别ANT配体、结合ANT的药剂和与ANT相互作用的药剂的组合物和方法。
• Cohesive coprecipitates of sulfated polysaccharide and fibrillar protein and use thereof
  申请人：Nevo Zvi

  公开号：US20060110426A1

  公开（公告）日：2006-05-25

  The present invention concerns cohesive biopolymer gels comprising coprecipitates of sulfated polysaccharides and fibrillar proteins, exemplified by coprecipitates of dextran sulfate and gelatin, useful for clinical applications including as implants for tissue engineering as well as in biotechnology. The cohesive biopolymer gels according to the present invention may be used clinically either per se or as a scaffold for a cell-bearing implant, as a depot for sustained release of bioactive agents, or for research and biotechnology.

  本发明涉及由硫酸化多糖和纤维蛋白共沉淀而成的凝聚性生物聚合物凝胶，例如由硫酸化右旋糖基聚合物和明胶共沉淀而成的凝胶，可用于临床应用，包括作为组织工程植入物以及生物技术。根据本发明的凝聚性生物聚合物凝胶可以在临床上直接使用，也可以作为细胞携带植入物的支架、生物活性物质持续释放的沉积物，或用于研究和生物技术。
• PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR
  申请人：Anderson M. Christen

  公开号：US20050003353A1

  公开（公告）日：2005-01-06

  Compositions and methods are provided for producing adenine nucleotide translocator (ANT) polypeptides and fusion proteins, including the production and use of recombinant expression constructs having a regulated promoter. ANT ligands and compositions and methods for identifying ANT ligands, agents that bind ANT and agents that interact with ANT are also disclosed.

  本发明提供了用于生产腺嘌呤核苷转运蛋白（ANT）多肽和融合蛋白的组合物和方法，包括具有调节启动子的重组表达构建的生产和使用。还公开了ANT配体以及用于识别ANT配体、结合ANT的药剂和与ANT相互作用的药剂的组合物和方法。
• Process for recovering adsorbent for use in extracorporeal circulation treatment
  申请人：KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA

  公开号：EP0187670A2

  公开（公告）日：1986-07-16

  A process for recovering the adsorption capacity of the adsorbent for use in extracorporeal circulation treatment, wherein polyanion compound is immobilized on a water-insoluble support, characterized by that the adsorbent after adsorption is washed with an aqueous electrolytic solution with a concentration of 0.18 to 6 mole/(. According to the process of the present invention, the adsorbent after adsorption can be recovered quickly and simply with sufficient safety and the recovered adsorbent for use in extracorporeal circulation treatment has almost unchanged selectively and saturated amount of adsorption, which also lower the cost of treatment

  一种回收体外循环治疗用吸附剂吸附能力的工艺，其中多阴离子化合物固定在不溶于水的支持物上，其特征在于吸附后的吸附剂用浓度为0.18至6摩尔/(的电解水溶液洗涤。 根据本发明的工艺，吸附后的吸附剂可以在足够安全的情况下快速简单地回收，回收后的体外循环治疗用吸附剂具有几乎不变的选择性和饱和吸附量，也降低了治疗成本。
• REMEDIES
  申请人：Takara Shuzo Co, Ltd.

  公开号：EP1175907A1

  公开（公告）日：2002-01-30

  The present invention provides a therapeutic agent or prophylactic agent for a disease requiring induction of growth factor production, a food, beverage or feed for induction of growth factor production, a cosmetic for induction of growth factor production, and a controlling agent for growth factor production, characterized in that each comprises as an effective ingredient a compound selected from the group consisting of acidic polysaccharides, degradation products thereof, acidic oligosaccharides, acidic monosaccharides, acidic sugar alcohols and salts thereof, wherein the compound has induction action for growth factor production.

  本发明提供了一种用于需要诱导生长因子产生的疾病的治疗剂或预防剂，一种用于诱导生长因子产生的食品、饮料或饲料，一种用于诱导生长因子产生的化妆品，以及一种用于生长因子产生的控制剂、其特征在于，每种物质都包含一种选自酸性多糖、其降解产物、酸性寡糖、酸性单糖、酸性糖醇及其盐类的化合物作为有效成分，其中该化合物具有诱导生长因子产生的作用。